# Fractional CO2 Laser Fenestration and Steroid Delivery in HS Lesions

> **NCT05580029** · EARLY_PHASE1 · UNKNOWN · sponsor: **University of Southern California** · enrollment: 10 (estimated)

## Conditions studied

- Scar
- Hidradenitis Suppurativa

## Interventions

- **DEVICE:** Triamcinolone Topical
- **PROCEDURE:** Fractional Ablative CO2 Therapy
- **DRUG:** EMLA 5% cream

## Key facts

- **NCT ID:** NCT05580029
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-01
- **Primary completion:** 2023-01-20
- **Final completion:** 2023-03-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05580029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05580029, "Fractional CO2 Laser Fenestration and Steroid Delivery in HS Lesions". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05580029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*